Impel Pharmaceuticals Inc.
IMPL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $87,919 | $126,001 | $197,084 | $197,084 |
| - Cash | $60,654 | $88,212 | $7,095 | $37,001 |
| + Debt | $51,186 | $29,450 | $8,411 | $0 |
| Enterprise Value | $78,451 | $67,239 | $198,400 | $160,083 |
| Revenue | $12,652 | $668 | $0 | $0 |
| % Growth | 1,794% | – | – | – |
| Gross Profit | $6,157 | -$23 | $0 | $0 |
| % Margin | 48.7% | -3.4% | – | – |
| EBITDA | -$91,276 | -$70,398 | -$44,257 | -$40,844 |
| % Margin | -721.4% | -10,538.6% | – | – |
| Net Income | -$129,440 | -$76,536 | -$45,798 | -$41,859 |
| % Margin | -1,023.1% | -11,457.5% | – | – |
| EPS Diluted | -5.52 | -5.24 | -3.49 | -3.19 |
| % Growth | -5.3% | -50.1% | -9.4% | – |
| Operating Cash Flow | -$93,642 | -$66,364 | -$39,183 | -$36,487 |
| Capital Expenditures | -$1,377 | -$408 | -$1,782 | -$1,523 |
| Free Cash Flow | -$95,019 | -$66,772 | -$40,965 | -$38,010 |